CME Group Inc.
NASDAQ:CMEFinancial - Data & Stock Exchanges
-$6.03 today
- Market cap
- $111.05B
- Beta
- 0.24
- P/E (TTM)
- 20.9
- EPS (TTM)
- $11.81
- Dividend yield
- 4.56%
Volume 2.01M
Average 2.82M
CME Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
CME Group Inc.NASDAQ: CME
Net Change in Cash · Q3 FY2026 · quarter ended Sep 2026
Net change in cash outflow shrinks to $0
Q3 FY2026 net change in cash was $0, compared with $7.35B a year earlier. Trailing-twelve-month net change in cash was $8.76B.
Context
- Net change in cash amounted to 955.2% of revenue in FY2025, up 813.5 pp from a year earlier.
- Net change in cash increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly net change in cash holds near $0 or moves back toward the trailing-twelve-month quarterly average of $2.19B.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- 62.29B USD
- Year-over-year change
- +617.2%
- 4-year CAGR
- -3.7%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 62.29B | +617.2% |
| FY2024 | 2024-12-31 | 8.68B | +119.4% |
| FY2023 | 2023-12-31 | (44.86B) | -96.6% |
| FY2022 | 2022-12-31 | (22.82B) | -131.5% |
| FY2021 | 2021-12-31 | 72.37B | — |
Net Change in Cash vs competitors
How CME compares with its peers on the latest reported figures
- CME's LTM Sep 2026 net change in cash of $8.76B is the 2nd largest of the 4 companies compared; the peer median is $420.59M.
- Its year-over-year change of -82.4% is the lowest of 4, against a peer median of +506.6%.
- Net change in cash amounts to 125.7% of revenue for CME, versus a peer median of 36.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $37.27B | +506.6% | +15.1% | 298.7% | |
| LTM Sep 2026 | $8.76B | -82.4% | — | 125.7% | |
| LTM Sep 2026 | $3.29B | +143.2% | — | 36.0% | |
| LTM Jun 2026 | $420.59M | +577.4% | +37.7% | 19.1% | |
| Peer median (excluding CME) | $420.59M | +506.6% | +26.4% | 36.0% | |
Competitors are the stored peer set for CME. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.64B | 2.69B | 3.23B | 3.53B | 4.07B |
| Depreciation & Amortization | 385.4M | 362.6M | 352.6M | 336.8M | 330.9M |
| Deferred Income Tax | 34.8M | (23.2M) | (75M) | (66.4M) | (6.1M) |
| Stock-Based Compensation | 75.2M | 84.3M | 82.9M | 89.5M | 94.8M |
| Change in Working Capital | (161.8M) | (95.2M) | (95.2M) | (191.6M) | 99.7M |
| Accounts Receivables | (45.7M) | (51.1M) | (51.5M) | (39.4M) | (67.1M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (18.6M) | 72.5M | (30.8M) | (10.7M) | (8.1M) |
| Other Working Capital | (97.5M) | (116.6M) | (12.9M) | (141.5M) | 174.9M |
| Other Non-Cash Items | (568.1M) | 36.5M | (37.7M) | (3.6M) | (314.4M) |
| Operating Cash Flow | 2.4B | 3.06B | 3.45B | 3.69B | 4.28B |
| Capital Expenditures | (127.2M) | (89.7M) | (76.4M) | (94M) | (83.5M) |
| Acquisitions (Net) | 144.7M | (402M) | 95.5M | 9.9M | 1.58B |
| Purchases of Investments | (7.8M) | (4.4M) | (4.1M) | (4.5M) | (6M) |
| Sales of Investments | 9.4M | 6.3M | 5.9M | 6M | 7.9M |
| Other Investing Activities | 39.3M | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 58.4M | (489.8M) | 20.9M | (82.6M) | 1.5B |
| Debt Repayment | 0 | (15.2M) | (16.4M) | 0 | (9.4M) |
| Common Stock Issued | 965M | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (24.8M) | (21.4M) | (33M) | (266.1M) |
| Dividends Paid | (2.19B) | (2.63B) | (3.24B) | (3.58B) | (3.93B) |
| Other Financing Activities | 71.13B | (22.71B) | (45.07B) | 8.69B | 60.72B |
| Financing Cash Flow | 69.91B | (25.38B) | (48.34B) | 5.08B | 56.51B |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 72.37B | (22.82B) | (44.86B) | 8.68B | 62.29B |
| Free Cash Flow | 2.28B | 2.97B | 3.38B | 3.6B | 4.19B |
CME Group Inc.
NASDAQ:CME
Intrinsic Alpha fair value
Locked
Current Price
$310.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.